KPWS
NAUT icon

Kestra Private Wealth Services’s Nautilus Biotechnolgy NAUT Stock Holding History

Kestra Private Wealth Services’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-11,897
Closed -$37.6K – 1265
2023
Q3 		$37.6K Buy
+11,897
New +$38.7K ﹤0.01% 1135

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Kestra Private Wealth Services's NAUT Position: Q4 2023 in Review

Kestra Private Wealth Services sold out of Nautilus Biotechnolgy (NAUT) in Q4 2023, closing a stake of 11,897 shares — an estimated $37.6K sold.

Kestra Private Wealth Services first reported a position in NAUT in Q3 2023 and held it in 1 quarter. The position peaked at $37.6K in Q3 2023. 76 funds tracked by Wall St. Rank hold NAUT as of Q4 2023.

  • Kestra Private Wealth Services reported no remaining Nautilus Biotechnolgy position as of Q4 2023 after selling out during the quarter.
  • Kestra Private Wealth Services sold 11,897 Nautilus Biotechnolgy shares in Q4 2023, an estimated $37.6K.
  • Kestra Private Wealth Services first reported a position in Nautilus Biotechnolgy in Q3 2023 and held it in 1 quarter.
  • Kestra Private Wealth Services's Nautilus Biotechnolgy position peaked at $37.6K in Q3 2023.
  • 76 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q4 2023.

Based on Kestra Private Wealth Services's 13F filing for Q4 2023, filed 5 Feb 2024.